Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
09/2012
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012CA2606521C Dihydropyridine derivatives
09/18/2012CA2501717C Use of epothilone derivatives for the treatment of hyperparathyroidism
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012121140A1 Growth hormone secretion promoter
09/13/2012WO2012120476A1 Substituted morpholines as modulators for the calcium sensing receptor
09/13/2012WO2012119559A1 Androgen receptor antagonists and uses thereof
09/13/2012WO2012053003A8 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
09/13/2012WO2011103130A8 Aminothiazolones as estrogen related receptor-alpha modulators
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232009 Methods for Treatment of Insulin-Like Growth Factor-1 Deficiency
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012CA2829322A1 Androgen receptor antagonists and uses thereof
09/13/2012CA2828415A1 Substituted morpholines as modulators for the calcium sensing receptor
09/12/2012CN102666586A Drug fusions and conjugates with extended half life
09/12/2012CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/12/2012CN102666508A Phenyloxadiazole derivatives as pgds inhibitors
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102657640A PTP1B (protein tyrosine phosphatase 1B) inhibition activity of norathyriol, and application of norathyriol
09/12/2012CN102657639A Application of carthamin yellow to aspects of reducing fat and increasing sensitivity of insulin
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101715956B Multifunctional health juice with stable effective ingredients and processing method thereof
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101506221B Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
09/12/2012CN101189251B 17 beta-HSD1 and STS inhibitors
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263084 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
09/11/2012US8262054 Furnace mount
09/07/2012WO2012080284A3 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
09/07/2012CA2829020A1 Parathyroid hormone analogs, compositions and uses thereof
09/06/2012US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225887 Glucokinase Activators
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225878 Compounds
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225865 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
09/06/2012US20120225863 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225853 Hormone replacement therapy and depression
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225816 Pharmaceutical Compositions of Melanocortin Receptor Ligands
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225069 Use of a compound for reducing the biological effectiveness of il-6
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012DE102011004899A1 New 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl-deriva tives are progesterone receptor antagonists useful to treat and prevent e.g. uterine fibroids, endometriosis, heavy menstrual bleeding and meningioma
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493888A1 Bicyclic pyridines and analogs as sirtuin modulators
09/05/2012EP2493303A1 2- [1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA [F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
09/05/2012CN102655867A Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
09/05/2012CN102652828A Polypeptide-k buccal tablet
09/05/2012CN102652808A Menstruation regulating and beautifying capsule
09/05/2012CN102652757A Application of health-care drinking liquid containing deep seawater in preparation of medicaments or health-care products for preventing or treating metabolic syndrome
09/05/2012CN102652749A Application of 2-cycloxyl substituted or cyclothio substituted hydroxyacetophenone in treatment of metabolic disease
09/05/2012CN102091082B Ginsenoside Rb3 composition and application thereof in preparing medicament for treating diabetes
09/05/2012CN101972315B Use of traditional Chinese medicinal composition
09/05/2012CN101780242B Health or medicine composition and preparation method and application thereof
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101588804B Method for treating or preventing symptoms of hormonal variations
09/05/2012CN101443016B Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
09/04/2012US8258293 Tetrahydroquinoline derivatives
09/04/2012US8258252 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer
09/04/2012US8258134 Pyridazinone glucokinase activators
09/04/2012US8258096 Therapy procedure for drug delivery for trigeminal pain
09/04/2012US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle
09/04/2012CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
08/2012
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115064A1 Ppar activator
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220556 Drospirenone for hormone replacement therapy
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture
08/29/2012EP2490674A2 Melt-granulated cinacalcet
08/29/2012CN1820782B Thyroid hormone medicinal preparation and its preparing method
08/29/2012CN102038721B Pinus extract and application thereof
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252745 Methods for treatment of headaches by administration of oxytocin
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2453337C Methods and materials for the treatment of testosterone deficiency in men
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214777 Stabilized compositions containing alkaline labile drugs
08/23/2012US20120214773 Formulation for lipophilic agents
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 290